U.S. Vice President Mike Pence received his Covid-19 vaccine live on television on Dec. 18, seeking to shore up public support for vaccinations after U.S. deaths...
NY Sees Record 12K+ COVID-19 Cases; Pence Vaccinated Live On Camera: Live Updates Tyler Durden Fri, 12/18/2020 - 11:49 Summary: NY suffers worst daily case numbers...
Interim data expected by late January.
US Suffers New COVID 'Case' Record As VP Pence Joins 1.1MM Vaccinated In West: Live Updates Tyler Durden Fri, 12/18/2020 - 09:32 Summary: Hospitalizations trend higher...
The FDA is looking to quickly approve Moderna’s COVID-19 vaccine after it was unanimously backed by a panel vote of 20-0-1
AAR shares fell 4.7% in after-hours trading on Thursday after it reported a year-on-year decline of 28% in its Q2 consolidated sales of $403.6 million. It...
A panel of outside advisers to the U.S. Food and Drug Administration overwhelmingly endorsed emergency use of Moderna Inc.’s coronavirus vaccine, virtually assuring a second option...
FDA Advisory Panel Confirms Moderna's COVID-19 Vaccine Benefits Outweigh Risks Tyler Durden Thu, 12/17/2020 - 17:06 Following last week's Pfizer approval, this one just seems a...
The rollout of Pfizer’s COVID-19 vaccine has had a few hiccups, but it’s going smoothly for the most part
The earliest Moderna probably would have sold the mRNA-1273 vaccine would have been after it began scaling up manufacturing. A company doesn’t begin manufacturing until it...
The major indices closed mixed on Wednesday (Dec. 16), as the Nasdaq hit yet another record close amidst stimulus optimism and the Fed’s dovish tone. Q3...
A panel of outside advisers to the U.S. Food and Drug Administration is expected to endorse emergency use of Moderna Inc.’s coronavirus vaccine during a meeting...
U.S. coronavirus deaths soared to a daily record of 3,580 and hospitalizations rose for the 19th straight day on Dec. 16, ramping up the stakes as...
Surface Oncology agreed to grant exclusive worldwide licensing rights to GlaxoSmithKline for the development and commercialization of the Cambridge, Mass.-based biotech company’s SRF813, a fully human...
As we hunker down this holiday season, waiting for our vaccines, or at least until the diffusion of the vaccines has slowed the spread of the...
Trials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the The post Trials of Valneva COVID-19 vaccine begin...
BIOTRONIK won FDA clearance for the Vital Data Sensor, a body temperature component within the BIOMONITOR IIIm injectable cardiac monitor (ICM). The ICM is designed to...
Merck & Co. announced on Thursday that the US Food and Drug Administration (FDA) has granted priority review for the use of its lead drug Keytruda in...
A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company The post Ardelyx’s ambition to revolutionise kidney treatment...
BioNTech and Shanghai Fosun Pharmaceutical announced an agreement for the supply of an initial 100 million doses of their COVID-19 vaccine BNT162 to mainland China in...
While Pfizer and the US government are still negotiating for more doses of its BioNTech-partnered mRNA vaccine, the FDA has cleared the way for pharmacists to...
Abbott Laboratories has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for its virtually guided at-home BinaxNow COVID-19 Ag Card...
Trials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the The post Trials of fifth COVID-19 vaccine begin...
Favorable COVID-19 vaccine developments have revived the hopes of several companies that have seen demand for their products crushed by the unprecedented pandemic. That said, the...
Lexicon Pharmaceuticals has entered into a collaboration agreement with AC Bioscience, enabling the use of preclinical and clinical data for LX2931, without granting any right or...
CNBC Transcript: Dr. Anthony Fauci speaks with CNBC ’s Meg Tirrell live during the CNBC Healthy Returns Livestream today and gives his predictions for coronavirus after...
Why The Number '3' May Make You Rethink The COVID Hysteria Tyler Durden Wed, 12/16/2020 - 13:52 Authored by Simon Black via SovereignMan.com, Yesterday I promised...
FDA Approves First Rapid At-Home COVID Test
Stocks rose sharply on Tuesday (Dec. 15) as optimism grew that Congress could pass another COVID stimulus package before year’s end. Q3 2020 hedge fund letters,...
A roundup of biopharma news and updates includes Merck and Eisai’s Keytruda-Lenvima combo hitting the mark in a Phase III study for advanced endometrial cancer.